within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01A_AlkylatingAgents.L01AA09_Bendamustine;

model Bendamustine
  extends Pharmacolibrary.Drugs.ATC.L.L01AA09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01AA09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Bendamustine is an alkylating antineoplastic agent used primarily in the treatment of hematological malignancies such as chronic lymphocytic leukemia (CLL), indolent non-Hodgkin lymphoma (NHL), and multiple myeloma. It is administered intravenously, and is approved for medical use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma after intravenous infusion.</p><h4>References</h4><ol><li><p>Cracchiolo, MJ, et al., &amp; Katsanis, E (2024). Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. <i>Cancer chemotherapy and pharmacology</i> 94(3) 361–372. DOI:<a href=&quot;https://doi.org/10.1007/s00280-024-04688-y&quot;>10.1007/s00280-024-04688-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38878208/&quot;>https://pubmed.ncbi.nlm.nih.gov/38878208</a></p></li><li><p>Darwish, M, et al., &amp; Chovan, JP (2015). Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites. <i>Cancer chemotherapy and pharmacology</i> 75(6) 1143–1154. DOI:<a href=&quot;https://doi.org/10.1007/s00280-015-2727-6&quot;>10.1007/s00280-015-2727-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25829094/&quot;>https://pubmed.ncbi.nlm.nih.gov/25829094</a></p></li><li><p>Jairam, RK, et al., &amp; Mullangi, R (2019). Prediction of Human Pharmacokinetics of Bendamustine from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles. <i>Drug research</i> 69(1) 32–39. DOI:<a href=&quot;https://doi.org/10.1055/a-0640-8977&quot;>10.1055/a-0640-8977</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29996173/&quot;>https://pubmed.ncbi.nlm.nih.gov/29996173</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bendamustine;
